Latest from Christopher Rowland
The pharmaceutical company petitioned the U.S. Patent and Trademark Office, seeking a reexamination of the government’s patents.
  • Aug 21, 2019
Two young children will receive a novel drug to treat spinal muscular atrophy.
  • Jul 18, 2019
Nearly 2,000 communities hurt by the opioid crisis are suing drug companies for staggering sums of money to cover the costs of treatment, education and law enforcement.
  • Jul 17, 2019
Not all kids with spinal muscular atrophy are qualifying for insurance coverage of the new cutting-edge treatment.
  • Jul 10, 2019
Medicare must do more to prevent patient harm, the Health and Human Services inspector general said in a report issued Tuesday.
  • Jul 9, 2019
A hunt for hope amid the wreckage of Alzheimer’s drugs
  • Jul 3, 2019
Study finds 60 percent surge in air ambulance prices over the last four years
  • Jul 1, 2019
The House Oversight Committee chairman wants to know if there was a link to Gilead’s patent claims.
  • Jun 27, 2019
The storefront urgent-care clinics, an integral part of the regional health system, enjoys patient and staff loyalty.
  • Jun 21, 2019
Amgen, Eli Lilly, and Merck filed a lawsuit against the Trump administration.
  • Jun 14, 2019